OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion
Shintaro Okumura, Yusuke Konishi, Megumi Narukawa, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 156

Showing 26-50 of 156 citing articles:

Male‐Biased Gut Microbiome and Metabolites Aggravate Colorectal Cancer Development
Ling Wang, Yi‐Xuan Tu, Lu Chen, et al.
Advanced Science (2023) Vol. 10, Iss. 25
Open Access | Times Cited: 23

Identification of colorectal cancer progression-associated intestinal microbiome and predictive signature construction
Jungang Liu, Xiaoliang Huang, Chuanbin Chen, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 22

Porphyromonas gingivalis in Colorectal Cancer and its Association to Patient Prognosis
Maïwenn Kerdreux, Sofia Edin, Thyra Löwenmark, et al.
Journal of Cancer (2023) Vol. 14, Iss. 9, pp. 1479-1485
Open Access | Times Cited: 22

The gut microbiome-prostate cancer crosstalk is modulated by dietary polyunsaturated long-chain fatty acids
Gabriel Lachance, Karine Robitaille, Jalal Laaraj, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12

A systematic framework for understanding the microbiome in human health and disease: from basic principles to clinical translation
Ziqi Ma, Tao Zuo, Norbert Frey, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 12

Multi-kingdom microbial signatures in excess body weight colorectal cancer based on global metagenomic analysis
Xinyue Zhu, Pingping Xu, Ruixin Zhu, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 10

The relationship between the gut microbiota and thyroid disorders
Marian Ludgate, Giulia Masetti, Paula Soares
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 9, pp. 511-525
Closed Access | Times Cited: 9

Reprogramming of glucose metabolism: The hallmark of malignant transformation and target for advanced diagnostics and treatments
Qing Tang, Siqi Wu, Baiming Zhao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117257-117257
Open Access | Times Cited: 9

The Role of the Gut Microbiota in Modulating Signaling Pathways and Oxidative Stress in Glioma Therapies
Aleksandra Krawczyk, Gabriela Elzbieta Sladowska, Barbara Strzałka‐Mrozik
Cancers (2025) Vol. 17, Iss. 5, pp. 719-719
Open Access | Times Cited: 1

The intestinal barrier: a pivotal role in health, inflammation, and cancer
Markus F. Neurath, David Artis, Christoph Becker
˜The œLancet. Gastroenterology & hepatology (2025)
Open Access | Times Cited: 1

Exploring the oral-gut linkage: Interrelationship between oral and systemic diseases
Kyoko Yamazaki, Nobuhiko Kamada
Mucosal Immunology (2023) Vol. 17, Iss. 1, pp. 147-153
Open Access | Times Cited: 21

Gut Microbial-Derived Metabolites as Immune Modulators of T Helper 17 and Regulatory T Cells
Laura Calvo‐Barreiro, Longfei Zhang, Somaya A. Abdel‐Rahman, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1806-1806
Open Access | Times Cited: 20

Beneficial insights into postbiotics against colorectal cancer
Dingka Song, Xiuli Wang, Yongjing Ma, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 18

Microbiome-targeted interventions for the control of oral–gut dysbiosis and chronic systemic inflammation
Juan Pacheco‐Yanes, Eric C. Reynolds, Jian Li, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 11, pp. 912-925
Closed Access | Times Cited: 18

The role of gut microbiota and metabolites in cancer chemotherapy
Shiyu Li, Shuangli Zhu, Jun Yu
Journal of Advanced Research (2023) Vol. 64, pp. 223-235
Open Access | Times Cited: 17

Gut dysbiosis in autoimmune diseases: Association with mortality
Sung-Ho Chang, Youngnim Choi
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 16

The Role of Microbiota-Derived Metabolites in Colorectal Cancer
Coco Duizer, Marcel R. de Zoete
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8024-8024
Open Access | Times Cited: 16

Role of short‐chain fatty acids in host physiology
Mingyue Liu, Yubo Lu, Guoyu Xue, et al.
Animal Models and Experimental Medicine (2024) Vol. 7, Iss. 5, pp. 641-652
Open Access | Times Cited: 7

Gut microbiota and immunosenescence in cancer
Yaozheng Xu, Chuan He, Ying Xi, et al.
Seminars in Cancer Biology (2024) Vol. 104-105, pp. 32-45
Closed Access | Times Cited: 7

Biomarker Profile of Colorectal Cancer: Current Findings and Future Perspective
Seyed Hamid Hoseini, Parisa Enayati, Majid Nazari, et al.
Journal of Gastrointestinal Cancer (2024) Vol. 55, Iss. 2, pp. 497-510
Closed Access | Times Cited: 6

Identification of KRAS mutation-associated gut microbiota in colorectal cancer and construction of predictive machine learning model
Zigui Huang, Xiaoliang Huang, Yili Huang, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 5
Open Access | Times Cited: 6

The connection between aging, cellular senescence and gut microbiome alterations: A comprehensive review
D.S. Jang, J W Shin, Eunha Shim, et al.
Aging Cell (2024) Vol. 23, Iss. 10
Open Access | Times Cited: 6

Autophagy: A Versatile Player in the Progression of Colorectal Cancer and Drug Resistance
Shaista Manzoor, Jibran Sualeh Muhammad, Azzam A. Maghazachi, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 25

Scroll to top